Miller Steve

Chief Op. & Scientific OfficerCATALYST PHARMACEUTICALS, INC. (CPRX) · full profile →Form 4 · filed Jul 17, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
11
1 non-derivative · 10 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 15, 2026Disposed to issuer(D)1.1M$31.50$34.5M0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 15, 2026Disposed to issuer(D)180K$00
Jul 15, 2026Disposed to issuer(D)275K$00
Jul 15, 2026Disposed to issuer(D)185K$00
Jul 15, 2026Disposed to issuer(D)146K$00
Jul 15, 2026Disposed to issuer(D)248K$00
Jul 15, 2026Disposed to issuer(D)203K$00
Jul 15, 2026Disposed to issuer(D)158K$00
Jul 15, 2026Disposed to issuer(D)12K$00
Jul 15, 2026Disposed to issuer(D)17K$00
Jul 15, 2026Disposed to issuer(D)48K$00

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001161697-26-000180) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.